[beta-receptor blockaders in cardiac arrhythmias].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D001146:Arrhythmia, Sinus / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001262:Atenolol / Q000627:therapeutic use; D001919:Bradycardia / Q000188:drug therapy; D004562:Electrocardiography; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D010096:Oxprenolol / Q000627:therapeutic use; D012849:Sinoatrial Node / Q000187:drug effects; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D001262:Atenolol; D010096:Oxprenolol
beta-Rezeptorenblocker bei kardialen Rhythmusstörungen.